News
Important Only
Other
CrowdStrike to lay off 5% of staff, reaffirms forecasts
May 7 (Reuters) - CrowdStrike CRWD.O reiterated its fiscal 2026 first quarter and annual forecasts on Wednesday and announced a plan to cut about 500 roles, roughly 5% of its workforce, to reduce costs.The cybersecurity company will incur about $36 million to $53 million in charges related to the la...Reuters
Wed, May 7
Other
France, Germany convinced economic reform must be coordinated, Macron says
PARIS, May 7 (Reuters) - France and Germany share the view that they must coordinate economic reform, French President Emmanuel Macron said on Wednesday.Macron was speaking alongside new German Chancellor Friedrich Merz at the Elysee palace in Paris.Merz is taking office as Europe scrambles to agree...Reuters
Wed, May 7
Other
Brazilian pulpmaker Klabin reports $78 million Q1 net profit
SAO PAULO, May 7 (Reuters) - Brazilian pulpmaker Klabin KLBN4.SA posted a net profit of 446 million reais ($78.06 million) in the first quarter, the company said in a securities filing on Wednesday. ($1 = 5.7135 reais)Reuters
Wed, May 7
Other
Atea Pharmaceuticals Announces Full Results From Phase 2 Study Of Regimen Of Bemnifosbuvir And Ruzasvir For Treatment Of Hepatitis C Virus (HCV) Presented At EASL Congress 2025
May 7 (Reuters) - Atea Pharmaceuticals Inc AVIR.O:ATEA PHARMACEUTICALS ANNOUNCES FULL RESULTS FROM PHASE 2 STUDY OF REGIMEN OF BEMNIFOSBUVIR AND RUZASVIR FOR TREATMENT OF HEPATITIS C VIRUS (HCV) PRESENTED AT EASL CONGRESS 2025Reuters
Wed, May 7
Other
Avista Corp. Reports Financial Results For The First Quarter Of 2025, Confirms 2025 Earnings Guidance
May 7 (Reuters) - Avista Corp AVA.N:AVISTA CORP. REPORTS FINANCIAL RESULTS FOR THE FIRST QUARTER OF 2025, CONFIRMS 2025 EARNINGS GUIDANCEAVISTA CORP - EARNINGS PER SHARE FOR Q1 2025 AT $0.98Reuters
Wed, May 7
Other
Dayforce Inc- Qtrly Total Revenue Was $481.8 Million
May 7 (Reuters) - Dayforce Inc DAY.N:QTRLY TOTAL REVENUE WAS $481.8 MILLIONQTRLY ADJUSTED EPS $0.58OUTLOOK Q2 TOTAL REVENUE OF $454 MILLION TO $460 MILLIONOUTLOOK FY TOTAL REVENUE OF $1,929 MILLION TO $1,944 MILLIONFY2025 REVENUE VIEW $1.93 BILLION -- LSEG IBES DATAQ2 REVENUE VIEW $465.5 MILLION -- ...Reuters
Wed, May 7
Other
Theriva Biologics Announces Primary Endpoints For Efficacy And Safety Achieved In VIRAGE Phase 2B Clinical Trial Of VCN-01 With Gemcitabine/NAB-Paclitaxel In Newly-Diagnosed Metastatic Pancreatic Cancer Patients
May 7 (Reuters) - Theriva Biologics Inc TOVX.A:THERIVA™ BIOLOGICS ANNOUNCES PRIMARY ENDPOINTS FOR EFFICACY AND SAFETY ACHIEVED IN VIRAGE PHASE 2B CLINICAL TRIAL OF VCN-01 WITH GEMCITABINE/NAB-PACLITAXEL IN NEWLY-DIAGNOSED METASTATIC PANCREATIC CANCER PATIENTSTHERIVA BIOLOGICS INC - VCN-01 RECEIVES O...Reuters
Wed, May 7
Stocks
Is SoFi Stock a Buy Now?
The market has been incredibly resilient during the past month, climbing back up from lows despite continued tariff uncertainty. It has recouped most of its 2025 losses although it's still down 5% this year.Investors seem confident in the country and the future, and it makes sense that they would al...The Motley Fool
Wed, May 7
Commodities
Almonty Enters Into Binding Offtake Agreement To Supply Tungsten Oxide Solely For U.S. Defense Applications
May 7 (Reuters) - Almonty Industries Inc AII.TO:ALMONTY ENTERS INTO BINDING OFFTAKE AGREEMENT TO SUPPLY TUNGSTEN OXIDE SOLELY FOR U.S. DEFENSE APPLICATIONSALMONTY ENTERS INTO BINDING OFFTAKE AGREEMENT TO SUPPLY TUNGSTEN OXIDE SOLELY FOR U.S. DEFENSE APPLICATIONSALMONTY INDUSTRIES INC - TPW TO PURCHA...Reuters
Wed, May 7
Other
Teva Reports Ninth Consecutive Quarter Of Growth In Q1 2025 With Key Innovative Medicines Growing ~40% 2025 Profit Outlook Improved
May 7 (Reuters) - Teva Pharmaceutical Industries Ltd TEVA.TA:TEVA REPORTS NINTH CONSECUTIVE QUARTER OF GROWTH IN Q1 2025 WITH KEY INNOVATIVE MEDICINES GROWING ~40%; 2025 PROFIT OUTLOOK IMPROVEDTEVA: ON TRACK FOR 30% OPERATING PROFIT MARGIN BY 2027 IN LINE WITH OUR PIVOT TO GROWTH STRATEGYTEVA: CURRE...Reuters
Wed, May 7
Other
ENHERTU (Fam-Trastuzumab Deruxtecan-Nxki) Followed By THP Before Surgery Showed Statistically Significant And Clinically Meaningful Improvement In Pathologic Complete Response In High-Risk HER2-Positive Early-Stage Breast Cancer In DESTINY-Breast11
May 7 (Reuters) - AstraZeneca PLC AZN.L:ENHERTU® (FAM-TRASTUZUMAB DERUXTECAN-NXKI) FOLLOWED BY THP BEFORE SURGERY SHOWED STATISTICALLY SIGNIFICANT AND CLINICALLY MEANINGFUL IMPROVEMENT IN PATHOLOGIC COMPLETE RESPONSE IN HIGH-RISK HER2-POSITIVE EARLY-STAGE BREAST CANCER IN DESTINY-BREAST11Reuters
Wed, May 7
Other
France, Germany to set up joint defense security council, Macron says
PARIS, May 7 (Reuters) - France and Germany will set up a joint defense security council that will meet regularly as part of their efforts to boost defense investments, French President Emmanuel Macron said on Wednesday.Macron was speaking alongside new German Chancellor Friedrich Merz at the Elysee...Reuters
Wed, May 7
Other
Alpayana Intends To Acquire At C$1.15 Per Share All Sierra Shares Tendered To Revised Offer
May 7 (Reuters) - Sierra Metals Inc SMT.TO:ALPAYANA INTENDS TO ACQUIRE AT C$1.15 PER SHARE ALL SIERRA SHARES TENDERED TO REVISED OFFERALPAYANA: INTENDS TO WAIVE ALL REMAINING CONDITIONS OF REVISED SIERRA OFFERReuters
Wed, May 7
Other
The New York Times Company Reports First-Quarter 2025 Results
May 7 (Reuters) - New York Times Co NYT.N:THE NEW YORK TIMES COMPANY REPORTS FIRST-QUARTER 2025 RESULTSNEW YORK TIMES CO OUTLOOK Q2 TOTAL SUBSCRIPTION REVENUE INCREASE 8 - 10%NEW YORK TIMES CO OUTLOOK Q2 TOTAL ADVERTISING REVENUE FLAT TO INCREASE LOW-SINGLE-DIGITSReuters
Wed, May 7
Other
PPF Increases Its Stake In ITIS Holding To 95%
May 7 (Reuters) - ITIS Holdings Inc [RIC:RIC:ITISO.UL]:CZECH INVESTMENT GROUP PPF: AGREED TO ACQUIRE ADDITIONAL SHARES OF ITIS HOLDING FROM ITIS CHIEF EXECUTIVE MATEJ OKÁLI, INCREASING ITS STAKE TO 95%Source text: [ID:]Further company coverage: ITISO.ULReuters
Wed, May 7
Other
New York Times forecasts quarterly subscription revenue growth above estimates
May 7 (Reuters) - The New York Times NYT.N forecast second-quarter subscription revenue growth above Wall Street estimates on Wednesday, betting on strong demand for its bundled offerings.The news publisher expects subscription revenue growth of 8% to 10%, compared with analysts' average estimat...Reuters
Wed, May 7
